7Baggers

10x Genomics, Inc
(NASDAQ:TXG) 

TXG stock logo

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluid...

Founded: 2012
IPO Price: $39 (Sep 12, 2019)
Full Time Employees: 1,243 (Dec 2022)
Founder: Serge Saxonov, Ben Hindson, Kevin Ness 
CEO: Serge Saxonov  
Sector: Healthcare
Industry: Health Information Services

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 
                               
      products and services revenue
    149,896,000 165,689,000 148,019,000 145,157,000 137,823,000                       
      license and royalty revenue
    947,000 341,000 983,000 27,751,000 17,060,000                       
      revenue
    150,843,000 166,030,000 149,002,000 172,908,000 154,883,000 165,021,000 151,654,000 153,104,000 141,006,000 183,979,000 153,644,000 146,819,000 134,285,000 156,232,000 131,072,000 114,609,000 114,496,000 143,530,000 125,297,000 115,842,000 105,821,000 112,218,000 71,817,000 42,905,000 71,905,000 75,289,000 61,207,000 
      yoy
    -2.61% 0.61% -1.75% 12.93% 9.84% -10.30% -1.30% 4.28% 5.01% 17.76% 17.22% 28.10% 17.28% 8.85% 4.61% -1.06% 8.20% 27.90% 74.47% 170.00% 47.17% 49.05% 17.33%     
      qoq
    -9.15% 11.43% -13.83% 11.64% -6.14% 8.81% -0.95% 8.58% -23.36% 19.74% 4.65% 9.33% -14.05% 19.20% 14.36% 0.10% -20.23% 14.55% 8.16% 9.47% -5.70% 56.26% 67.39% -40.33% -4.49% 23.01%  
      cost of products and services revenue
    44,665,000 52,985,000 48,695,000 47,824,000 49,438,000                       
      gross profit
    106,178,000 113,045,000 100,307,000 125,084,000 105,445,000 110,955,000 106,393,000 104,220,000 92,914,000 115,782,000 95,529,000 99,612,000 98,390,000 119,405,000 100,695,000 86,905,000 89,018,000 115,932,000 100,779,000 110,927,000 88,761,000 93,321,000 57,406,000 32,853,000 56,797,000 58,707,000 45,727,000 
      yoy
    0.70% 1.88% -5.72% 20.02% 13.49% -4.17% 11.37% 4.63% -5.57% -3.03% -5.13% 14.62% 10.53% 3.00% -0.08% -21.66% 0.29% 24.23% 75.55% 237.65% 56.28% 58.96% 25.54%     
      qoq
    -6.07% 12.70% -19.81% 18.62% -4.97% 4.29% 2.09% 12.17% -19.75% 21.20% -4.10% 1.24% -17.60% 18.58% 15.87% -2.37% -23.22% 15.04% -9.15% 24.97% -4.89% 62.56% 74.74% -42.16% -3.25% 28.39%  
      gross margin %
    70.39% 68.09% 67.32% 72.34% 68.08% 67.24% 70.16% 68.07% 65.89% 62.93% 62.18% 67.85% 73.27% 76.43% 76.82% 75.83% 77.75% 80.77% 80.43% 95.76% 83.88% 83.16% 79.93% 76.57% 78.99% 77.98% 74.71% 
      operating expenses:
                               
      research and development
    56,847,000 55,969,000 57,194,000 61,224,000 64,245,000 66,968,000 66,174,000 62,918,000 68,638,000 65,267,000 66,507,000 71,460,000 67,098,000 63,614,000 67,290,000 70,685,000 64,078,000 61,885,000 54,582,000 53,402,000 41,883,000 39,705,000 30,143,000 27,535,000 25,992,000 27,889,000 22,209,000 
      selling, general and administrative
    66,377,000 76,617,000 75,355,000 74,434,000 89,728,000 93,826,000 81,704,000 83,039,000 85,774,000 86,125,000 82,415,000 91,510,000 83,280,000 78,887,000 73,401,000 79,337,000 66,675,000 69,877,000 62,076,000 68,703,000 56,904,000 55,974,000 51,549,000 44,416,000 50,387,000 38,756,000 32,614,000 
      gain on settlement
       -40,700,000 -9,200,000                       
      total operating expenses
    123,224,000 132,586,000 132,549,000 94,958,000 144,773,000 160,794,000 147,878,000 145,957,000 154,412,000 170,970,000 190,324,000 162,970,000 150,378,000 142,501,000 140,691,000 150,022,000 130,753,000 131,762,000 116,658,000 121,255,000 98,977,000 502,904,000 122,661,000 72,273,000 76,681,000 66,787,000 54,823,000 
      income from operations
    -17,046,000 -19,541,000 -32,242,000 30,126,000 -39,328,000 -49,839,000 -41,485,000 -41,737,000 -61,498,000 -55,188,000 -94,795,000 -63,358,000 -51,988,000 -23,096,000 -39,996,000 -63,117,000 -41,735,000 -15,830,000 -15,879,000 -10,328,000 -10,216,000 -409,583,000 -65,255,000 -39,420,000 -19,884,000 -8,080,000 -9,096,000 
      yoy
    -56.66% -60.79% -22.28% -172.18% -36.05% -9.69% -56.24% -34.13% 18.29% 138.95% 137.01% 0.38% 24.57% 45.90% 151.88% 511.13% 308.53% -96.14% -75.67% -73.80% -48.62% 4969.10% 617.40%     
      qoq
    -12.77% -39.39% -207.02% -176.60% -21.09% 20.14% -0.60% -32.13% 11.43% -41.78% 49.62% 21.87% 125.10% -42.25% -36.63% 51.23% 163.64% -0.31% 53.75% 1.10% -97.51% 527.67% 65.54% 98.25% 146.09% -11.17%  
      operating margin %
    -11.30% -11.77% -21.64% 17.42% -25.39% -30.20% -27.36% -27.26% -43.61% -30.00% -61.70% -43.15% -38.71% -14.78% -30.51% -55.07% -36.45% -11.03% -12.67% -8.92% -9.65% -364.99% -90.86% -91.88% -27.65% -10.73% -14.86% 
      other income:
                               
      interest income
    5,014,000 6,892,000 5,199,000 4,271,000 3,686,000 4,026,000 4,971,000 4,715,000 4,736,000 4,637,000 4,300,000 4,100,000 3,869,000 2,815,000 2,025,000 1,238,000 569,000 49,000 49,000 58,000 50,000 61,000 28,000 125,000 1,318,000 1,819,000 481,000 
      other income
    -815,000 -2,544,000 -1,165,000 2,603,000 2,136,000 245,500 2,078,000         -1,843,000  5,000 -599,000 521,000  1,216,000 361,000     
      total other income
    4,199,000 4,348,000 4,037,000 6,871,000 5,822,000 1,459,000 7,047,000 4,658,000 3,695,000 8,590,000 3,051,000 2,591,000 2,334,000   -714,000 41,000   370,000  960,000 -8,000     
      income before provision for income taxes
    -12,847,000 -15,193,000 -28,205,000 36,997,000 -33,506,000 -48,380,000 -34,438,000 -37,079,000 -57,803,000 -46,598,000 -91,744,000 -60,767,000 -49,654,000 -16,411,000 -40,035,000 -63,831,000 -41,694,000 -15,993,000 -16,648,000 -9,958,000 -11,116,000   -39,745,000 -20,845,000 -7,026,000 -9,595,000 
      provision for income taxes
    623,000 1,059,000 -733,000 2,459,000 852,000 648,000 1,315,000 818,000 2,146,000 2,354,000 1,242,000 1,647,000 1,093,000 804,000 1,879,000 627,000 719,000 2,456,000 523,000 1,094,000 435,000   422,000 298,000 108,000 8,000 
      net income
    -13,470,000 -16,252,000 -27,472,000 34,538,000 -34,358,000 -49,028,000 -35,753,000 -37,897,000 -59,949,000 -48,952,000 -92,986,000 -62,414,000 -50,747,000 -17,215,000 -41,914,000 -64,458,000 -42,413,000 -18,449,000 -17,171,000 -11,052,000 -11,551,000 -415,573,000 -65,848,000 -40,167,000 -21,143,000 -7,134,000 -9,603,000 
      yoy
    -60.80% -66.85% -23.16% -191.14% -42.69% 0.16% -61.55% -39.28% 18.13% 184.36% 121.85% -3.17% 19.65% -6.69% 144.10% 483.22% 267.18% -95.56% -73.92% -72.48% -45.37% 5725.25% 585.70%     
      qoq
    -17.12% -40.84% -179.54% -200.52% -29.92% 37.13% -5.66% -36.78% 22.46% -47.36% 48.98% 22.99% 194.78% -58.93% -34.97% 51.98% 129.89% 7.44% 55.37% -4.32% -97.22% 531.11% 63.94% 89.98% 196.37% -25.71%  
      net income margin %
    -8.93% -9.79% -18.44% 19.97% -22.18% -29.71% -23.58% -24.75% -42.52% -26.61% -60.52% -42.51% -37.79% -11.02% -31.98% -56.24% -37.04% -12.85% -13.70% -9.54% -10.92% -370.33% -91.69% -93.62% -29.40% -9.48% -15.69% 
      net income per share
    -0.1 -0.13 -0.22 0.28 -0.28 -0.41 -0.3 -0.32 -0.5 -0.41 -0.79 -0.53 -0.44 -0.15 -0.37 -0.57 -0.38 -0.17 -0.15 -0.1 -0.11 -4.09 -0.65 -0.41 -0.22 0.41 -0.33 
      weighted-average shares used for eps calculation
    128,291,153 124,749,885 125,502,291 123,755,409 122,606,091 120,451,550    117,165,036    113,858,684    110,347,937    101,151,675    39,091,366  
      interest expense
      3,000 -3,000   -2,000 -1,000 -1,000 -8,000 -1,000 -5,000 -19,000 -125,000 -114,000 -109,000 -128,000 -217,000 -219,000 -209,000 -221,000 -317,000 -397,000 -306,000 -662,000 -992,000 -708,000 
      cost of revenue
         54,066,000 45,261,000 48,884,000 48,092,000 68,197,000 58,115,000 47,207,000 35,895,000 36,827,000 30,377,000 27,704,000 25,478,000 27,598,000 24,518,000 4,915,000 17,060,000 18,897,000 14,411,000 10,052,000 15,108,000 16,582,000 15,480,000 
      in-process research and development
             19,578,000 41,402,000           406,911,000 40,637,000     
      weighted-average shares of common stock used in computing net loss per share, basic and diluted
          120,733,030 120,066,972 119,394,180  117,728,293 116,707,672 115,619,869  114,112,382 113,574,757 112,966,196  110,874,249 109,866,294 108,714,027   98,978,283 96,829,093   
      other expense
           -56,000 -1,040,000 3,961,000 -1,248,000 -1,504,000 -1,516,000 -1,048,250 -1,950,000  -400,000    -729,000   -144,000    
      accrued contingent liabilities
                       -850,000 190,000 314,000 332,000 322,000 302,000 142,000  
      total other expense
                 -178,000 -39,000   -163,000 -769,000  -900,000   -325,000 -961,000 1,054,000 -499,000 
      loss on extinguishment of debt
                            -1,521,000   
      other comprehensive income:
                               
      foreign currency translation adjustment
                     -172,000 136,000 10,000 98,000 2,000 -366,000 355,000 5,000 114,000 -126,000 
      comprehensive loss
                     -18,621,000 -17,035,000 -11,042,000 -11,453,000 -415,571,000 -66,214,000 -39,812,000 -21,138,000 -7,020,000 -9,729,000 
      income before benefit from income taxes
                         -408,623,000 -65,263,000     
      benefit from income taxes
                         6,950,000 585,000     
      weighted-average shares of common stock used in computing net income per share, basic and diluted
                          101,341,945     
      other expenses
                            -96,000 -103,250 -272,000 
      weighted-average shares of common stock used in computing net loss per share attributable to common stockholders, basic and diluted
                              29,184,218 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 
                                 
        assets
                                 
        current assets:
                                 
        cash and cash equivalents
      490,285,000 473,966,000 432,508,000 397,712,000 377,061,000 344,067,000 398,159,000 379,824,000 355,781,000 359,284,000 311,264,000 325,879,000 332,320,000 219,746,000 233,951,000 274,187,000 312,487,000 587,447,000 600,440,000 621,958,000 617,195,000 663,603,000 768,773,000 339,840,000 372,428,000 424,166,000 427,436,000 
        marketable securities
      49,563,000 49,443,000 49,576,000 49,549,000 49,844,000 49,335,000  269,000 16,033,000 29,411,000 45,643,000 65,506,000 85,970,000 210,238,000 218,435,000 225,546,000 226,836,000           
        accounts receivable
      39,031,000 47,013,000 43,779,000 49,977,000 52,549,000 87,862,000 83,525,000 91,178,000 91,305,000 114,832,000 103,847,000 87,685,000 77,940,000 104,211,000 83,549,000 76,204,000 76,526,000 85,254,000 78,430,000 59,680,000 57,408,000 51,208,000 36,026,000 22,726,000 30,851,000 33,371,000 26,150,000 
        other receivables
      17,106,000 35,480,000 52,813,000 69,090,000                        
        inventory
      53,487,000 56,341,000 61,956,000 68,968,000 74,710,000 83,107,000 94,050,000 88,272,000 83,189,000 73,706,000 80,917,000 83,687,000 82,307,000 81,629,000 78,629,000 70,646,000 63,697,000 59,966,000 51,141,000 44,087,000 38,507,000 29,959,000 25,118,000 21,758,000 19,357,000 15,270,000 13,305,000 
        prepaid expenses and other current assets
      20,261,000 22,208,000 19,195,000 20,365,000 25,566,000 20,016,000 18,159,000 19,612,000 20,785,000 18,789,000 20,177,000 18,683,000 20,857,000 16,578,000 14,350,000 19,141,000 17,762,000 13,896,000 14,065,000 13,298,000 14,442,000 13,029,000 11,083,000 9,411,000 7,096,000 8,033,000 7,253,000 
        total current assets
      669,733,000 684,451,000 659,827,000 655,661,000 579,730,000 584,387,000 593,893,000 579,155,000 567,093,000 596,022,000 562,348,000 582,940,000 601,894,000 635,035,000 629,422,000 666,232,000 697,335,000 747,591,000 744,104,000 757,174,000 745,716,000 774,366,000 900,451,000 451,584,000 429,732,000 480,840,000 474,144,000 
        property and equipment
      220,591,000 226,711,000 232,534,000 239,710,000 246,087,000 252,648,000 258,759,000 263,285,000 269,486,000 279,571,000 285,008,000 284,913,000 292,106,000 289,328,000 257,694,000 223,001,000 190,200,000 169,492,000 142,589,000 122,329,000 107,313,000 72,840,000 65,111,000 55,930,000 52,384,000 48,821,000 46,840,000 
        operating lease right-of-use assets
      58,390,000 60,450,000 63,650,000 62,700,000 55,577,000 57,290,000 59,579,000 60,872,000 62,850,000 65,361,000 69,192,000 71,049,000 74,738,000 69,882,000 71,095,000 73,425,000 75,680,000 60,918,000 60,715,000 54,125,000 56,353,000 46,983,000 45,379,000 43,137,000 44,048,000   
        goodwill
      4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000 4,511,000       
        intangible assets
      59,910,000 62,329,000 64,759,000 14,714,000 15,192,000 15,671,000 16,149,000 16,658,000 16,129,000 16,616,000 21,833,000 22,290,000 22,948,000 22,858,000 23,493,000 24,128,000 24,764,000 25,397,000          
        other noncurrent assets
      2,624,000 2,913,000 1,879,000 2,674,000 2,296,000 4,129,000 4,903,000 5,187,000 2,844,000 3,062,000 2,674,000 20,461,000 12,859,000 2,392,000 2,901,000 3,199,000 3,163,000 3,319,000          
        total assets
      1,015,759,000 1,041,365,000 1,027,361,000 979,970,000 903,393,000 918,636,000 937,794,000 929,668,000 922,913,000 965,143,000 948,540,000 989,638,000 1,014,030,000 1,028,980,000 996,207,000 1,001,591,000 1,003,251,000 1,018,826,000 990,572,000 977,579,000 954,033,000 929,341,000 1,042,544,000 582,802,000 610,384,000 605,923,000 572,815,000 
        liabilities and stockholders’ equity
                                 
        current liabilities:
                                 
        accounts payable
      17,425,000 12,733,000 18,069,000 15,938,000 10,068,000 12,909,000 26,210,000 21,248,000 20,216,000 15,738,000 18,836,000 23,124,000 29,317,000 21,599,000 21,594,000 26,731,000 18,956,000 17,351,000 17,037,000 16,181,000 15,578,000 4,709,000 9,490,000 9,916,000 13,505,000 13,028,000 11,959,000 
        accrued compensation and related benefits
      21,506,000 42,500,000 37,084,000 26,102,000 21,957,000 33,615,000 30,080,000 20,078,000 20,670,000 30,105,000 28,477,000 22,372,000 17,574,000 32,675,000 28,214,000 23,505,000 18,324,000 31,626,000 27,182,000 21,113,000 16,820,000 15,383,000 11,189,000 10,276,000 18,623,000 12,394,000 7,850,000 
        accrued expenses and other current liabilities
      33,680,000 39,971,000 35,766,000 39,063,000 45,483,000 41,165,000 37,770,000 42,437,000 42,424,000 56,648,000 36,256,000 34,088,000 47,386,000 59,779,000 61,989,000 53,222,000 44,095,000 50,909,000 46,187,000 36,157,000 32,665,000 43,453,000 38,583,000 19,442,000 20,093,000 24,448,000 14,267,000 
        deferred revenue
      24,342,000 23,902,000 22,139,000 21,449,000 20,949,000 20,658,000 17,760,000 16,436,000 14,296,000 13,150,000 11,143,000 9,217,000 8,530,000 7,867,000 6,665,000 6,473,000 5,434,000 5,340,000 5,505,000 5,274,000 4,481,000       
        operating lease liabilities
      11,330,000 10,985,000 10,543,000 9,669,000 9,443,000 9,286,000 9,415,000 10,820,000 11,127,000 11,521,000 10,005,000 9,286,000 9,199,000 9,037,000 8,393,000 7,977,000 7,637,000 5,131,000 4,464,000 4,905,000 6,156,000 5,936,000 4,976,000 3,938,000 3,453,000   
        contingent consideration, current
      5,315,000 23,363,000 23,723,000                         
        total current liabilities
      113,598,000 153,454,000 147,324,000 112,221,000 107,900,000 117,633,000 121,235,000 111,019,000 108,733,000 127,162,000 104,717,000 98,087,000 112,006,000 130,957,000 126,855,000 117,908,000 94,446,000 110,357,000 100,375,000 113,126,000 120,549,000 118,126,000 145,571,000 122,180,000 59,068,000 63,049,000 48,236,000 
        contingent consideration, noncurrent
      1,222,000 1,237,000 1,210,000                         
        operating lease liabilities, noncurrent
      70,059,000 73,376,000 76,442,000 77,075,000 70,631,000 73,327,000 76,461,000 78,662,000 81,049,000 83,849,000 88,468,000 90,331,000 92,843,000 86,139,000 87,833,000 91,040,000 93,538,000 76,847,000 75,735,000 65,917,000 66,344,000 57,042,000 56,618,000 55,228,000 56,166,000   
        deferred revenue, noncurrent
      10,138,000 10,501,000 10,871,000 11,270,000 12,569,000 12,513,000 12,349,000 11,358,000 9,787,000 8,814,000                834,000 1,202,000 
        other noncurrent liabilities
      6,418,000 6,471,000 6,394,000 6,125,000 5,398,000 5,029,000 4,945,000 4,571,000 4,510,000 4,275,000 10,139,000 7,919,000 6,796,000 6,141,000 5,727,000 9,127,000 8,582,000 8,240,000 8,427,000 8,136,000 8,866,000 3,930,000 4,052,000 2,902,000 1,545,000 1,091,000 951,000 
        total liabilities
      201,435,000 245,039,000 242,241,000 206,691,000 196,498,000 208,502,000 214,990,000 205,610,000 204,079,000 224,100,000 203,324,000 196,337,000 211,645,000 223,237,000 220,415,000 218,075,000 196,566,000 201,258,000 190,351,000 192,993,000 201,573,000 190,269,000 217,464,000 191,533,000 201,316,000 185,840,000 151,367,000 
        commitments and contingencies
                                 
        stockholders’ equity:
                                 
        preferred stock
                                 
        common stock
      2,000  2,000 2,000 2,000  2,000 2,000 2,000  2,000 2,000 2,000  2,000 2,000 2,000  2,000 2,000        
        additional paid-in capital
      2,338,269,000 2,306,690,000 2,279,319,000 2,239,924,000 2,208,665,000 2,177,672,000 2,140,789,000 2,106,752,000 2,063,657,000 2,025,890,000 1,981,359,000 1,936,750,000 1,883,930,000 1,839,397,000 1,793,388,000 1,757,671,000 1,714,860,000 1,680,865,000 1,644,897,000 1,612,227,000 1,569,059,000 1,544,218,000 1,214,655,000 714,630,000 692,617,000 682,494,000 676,839,000 
        accumulated deficit
      -1,524,061,000 -1,510,591,000 -1,494,339,000 -1,466,867,000 -1,501,405,000 -1,467,047,000 -1,418,019,000 -1,382,266,000 -1,344,369,000 -1,284,420,000 -1,235,468,000 -1,142,482,000 -1,080,068,000 -1,029,321,000 -1,012,106,000 -970,192,000 -905,734,000 -863,321,000 -844,872,000 -827,701,000 -816,649,000 -805,098,000 -389,525,000 -323,677,000 -283,510,000 -262,367,000 -255,233,000 
        accumulated other comprehensive income
      114,000 225,000 138,000 220,000   32,000       -4,335,000 -5,492,000 -3,965,000 -2,443,000           
        total stockholders’ equity
      814,324,000 796,326,000 785,120,000 773,279,000 706,895,000 710,134,000 722,804,000 724,058,000 718,834,000 741,043,000 745,216,000 793,301,000 802,385,000 805,743,000 775,792,000 783,516,000 806,685,000 817,568,000 800,221,000 784,586,000 752,460,000 739,072,000 825,080,000 391,269,000 409,068,000 420,083,000 421,448,000 
        total liabilities and stockholders’ equity
      1,015,759,000 1,041,365,000 1,027,361,000 979,970,000 903,393,000 918,636,000 937,794,000 929,668,000 922,913,000 965,143,000 948,540,000 989,638,000 1,014,030,000 1,028,980,000 996,207,000 1,001,591,000 1,003,251,000 1,018,826,000 990,572,000 977,579,000 954,033,000 929,341,000 1,042,544,000 582,802,000 610,384,000   
        stockholders' equity:
                                 
        preferred stock, 0.00001 par value...
                                 
        common stock, 0.00001 par value...
       2,000    2,000    2,000    2,000    2,000   2,000 2,000 2,000 2,000 2,000 2,000 2,000 
        restricted cash
        201,000        500,000 1,500,000 2,500,000 2,633,000 508,000 508,000 27,000 1,028,000 28,000 18,151,000 18,164,000 16,567,000 59,451,000 57,849,000 59,475,000 52,327,000 50,053,000 
        accumulated other comprehensive loss
          -367,000 -493,000  -430,000 -456,000 -429,000 -677,000 -969,000 -1,479,000         -50,000 -52,000  -41,000 -46,000 -160,000 
        accrued license fee, noncurrent
                       5,814,000 5,814,000 5,814,000 5,814,000 11,171,000 11,223,000 11,223,000 11,223,000 16,251,000  
        accrued contingent liabilities
                         29,496,000 44,849,000 44,173,000 77,558,000 75,176,000 73,314,000 68,658,000 62,501,000 
        accumulated other comprehensive gain
                       22,000 194,000 58,000 48,000   314,000    
        other non-current assets
                        30,056,000 30,841,000        
        other assets
                          31,542,000 26,678,000 26,129,000 26,150,000 24,745,000 23,935,000 1,778,000 
        term loans, current portion
                               9,882,000 7,383,000 
        deferred revenue, current
                           4,472,000 3,775,000 3,432,000 3,394,000 3,297,000 3,082,000 
        term loans, noncurrent portion
                               19,837,000 22,307,000 
        deferred rent, noncurrent
                               16,120,000 16,170,000 
        liabilities, convertible preferred stock and stockholders’ equity
                                 
        convertible preferred stock, 0.00001 par value...
                                 
        stockholders’ equity
                                 
        total liabilities, convertible preferred stock and stockholders’ equity
                               605,923,000 572,815,000 
        accrued legal expenses
                                3,695,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 
                                  
          operating activities:
                                  
          net loss
        -13,470,000 -16,252,000   -34,358,000 -49,028,000 -35,753,000 -37,897,000 -59,949,000 -48,952,000 -92,986,000 -62,414,000 -50,747,000 -17,215,000 -41,914,000 -64,458,000 -42,413,000 -18,449,000 -17,171,000 -11,052,000 -11,551,000   -40,167,000 -21,143,000 -7,134,000 
          adjustments to reconcile net loss to net cash from operating activities:
                                  
          stock-based compensation expense
        22,642,000 25,219,000 25,264,000 27,559,000 31,076,000 32,540,000 33,588,000 38,492,000 36,129,000 38,918,000 40,235,000 45,696,000 42,101,000 40,974,000 33,514,000 36,313,000 26,047,000 26,904,000 25,950,000 26,932,000 16,176,000  13,784,000    
          depreciation and amortization
        9,957,000 10,065,000 10,297,000 7,815,000 8,022,000 8,750,000 8,964,000 8,971,000 9,194,000 9,717,000 9,372,000 9,941,000 6,482,000 6,521,000 6,156,000 6,500,000 6,191,000 5,781,000 5,696,000 4,889,000 4,752,000 3,918,000 3,592,000 3,313,000 3,189,000 2,845,000 
          non-cash lease expense
        1,953,000                          
          fair value adjustments on contingent consideration
        -57,000 272,000                         
          asset and lease impairment charges
                                 
          other
        -193,000 -393,000 -434,000 -351,000 -575,000 -48,000 62,000 65,000 444,000 -43,000 -143,000 463,000 150,000              
          changes in operating assets and liabilities:
                                  
          accounts receivable
        7,980,000 -3,232,000 6,629,000 2,592,000 35,325,000 -4,370,000 7,683,000 122,000 23,516,000 -10,974,000 -16,165,000 -9,753,000 26,279,000 -20,621,000 -7,352,000 297,000 8,728,000 -6,825,000 -19,392,000 -1,635,000 -6,189,000 -15,193,000 -13,300,000 8,125,000 2,521,000 -7,222,000 
          other receivables
        18,129,000 17,334,000 16,276,000                        
          inventory
        2,702,000 5,582,000 7,287,000 7,026,000 8,058,000 9,619,000 -4,262,000 -5,197,000 -9,937,000 7,614,000 2,568,000 -1,862,000 -449,000 -1,431,000 -8,660,000 -7,365,000 -3,736,000 -8,783,000 -7,134,000 -5,601,000 -8,614,000 -4,753,000 -3,360,000 -2,401,000 -4,087,000 -1,964,000 
          prepaid expenses and other current assets
        1,945,000 -2,985,000 1,383,000 4,789,000 -5,530,000 -2,597,000 1,594,000 1,131,000 -2,029,000 1,217,000 -1,523,000 2,130,000 -4,253,000 -2,038,000 2,891,000 -1,475,000 -3,873,000 167,000 -150,000 514,000 -1,584,000 -1,902,000 -1,657,000 -2,307,000 601,000 -779,000 
          other noncurrent assets
        282,000 -1,601,000 -149,000 125,000 2,314,000 766,000 283,000 -2,349,000 216,000 -388,000 17,783,000 -7,603,000 -10,470,000 514,000 296,000 -42,000 157,000          
          accounts payable
        4,782,000 -5,418,000 -196,000 6,035,000 -2,547,000 -13,398,000 4,339,000 1,122,000 4,583,000 -3,206,000 -4,125,000 2,095,000 -781,000 -224,000 -4,180,000 7,387,000 2,875,000 -1,107,000 2,480,000 -1,174,000 10,885,000 -4,463,000 -497,000 -2,157,000 -653,000 2,215,000 
          accrued compensation and other related benefits
        -20,956,000 5,363,000 10,101,000 3,928,000 -11,745,000 3,729,000 9,885,000 -580,000 -9,380,000 1,532,000 6,144,000 4,816,000 -15,129,000 4,277,000 4,844,000 5,276,000 -13,283,000 4,469,000 6,138,000 4,428,000 1,302,000 4,222,000 811,000 -8,288,000 6,191,000 4,454,000 
          deferred revenue
        77,000 1,394,000 -190,000 -805,000 347,000 3,067,000 2,310,000 3,712,000 2,120,000 4,295,000 3,752,000 1,834,000 1,051,000 1,505,000 178,000 1,437,000 230,000 314,000 269,000 604,000 348,000 1,125,000 406,000 21,000 471,000 -153,000 
          accrued contingent consideration and assumed liabilities
        -613,000                          
          accrued expenses and other current liabilities
        -6,136,000 4,786,000 -7,048,000 -7,220,000 4,329,000 4,399,000 -5,008,000 547,000 -12,674,000 19,148,000 8,659,000 655,000 -161,000 469,000 7,789,000 -1,381,000 -3,541,000 1,672,000 3,985,000 702,000 -7,232,000 16,453,000 6,364,000 -1,485,000 4,585,000 3,221,000 
          operating lease liability
        -2,854,000 -2,720,000 -2,604,000 -2,355,000 -2,631,000 -2,721,000 -4,164,000 -2,638,000 -2,961,000 -2,807,000 -1,324,000 -2,232,000 -2,308,000 -1,857,000 -2,385,000 -1,824,000 -357,000 29,000 672,000 -1,746,000 -1,424,000 -1,739,000 -1,107,000 -704,000 -1,282,000  
          other noncurrent liabilities
        -50,000 75,000 281,000 680,000 360,000 130,000 332,000 65,000 249,000 635,000 401,000 -13,000 261,000 61,000 -3,360,000 151,000 206,000 -620,000 228,000 -775,000 -3,538,000 -569,000 1,125,000 1,415,000 -5,742,000 367,000 
          net cash from operating activities
        26,120,000 40,777,000 43,214,000 17,708,000 34,351,000 -6,748,000 21,641,000 7,496,000 -15,725,000 25,758,000 -25,304,000 -11,526,000 -4,125,000 13,723,000 -9,564,000 -16,963,000 -20,802,000 5,805,000 -26,216,000 3,120,000 -4,082,000 -130,175,000 -55,629,000 -29,518,000 -2,576,000 6,700,000 
          capital expenditures
        -1,479,000 -1,777,000 -853,000 -1,675,000 -1,495,000 -2,716,000 -4,387,000 -3,325,000 -1,011,000 -3,450,000 -21,653,000 -46,707,000 26,109,000 -39,734,000 -33,961,000 -15,563,000 -13,113,000 -27,618,000 -20,227,000 -14,568,000 -38,865,000 -21,339,000 -509,000 -7,096,000 -5,268,000 -8,575,000 
          free cash flows
        24,641,000 39,000,000 42,361,000 16,033,000 32,856,000 -9,464,000 17,254,000 4,171,000 -16,736,000 22,308,000 -46,957,000 -58,233,000 21,984,000 -26,011,000 -43,525,000 -32,526,000 -33,915,000 -21,813,000 -46,443,000 -11,448,000 -42,947,000 -151,514,000 -56,138,000 -36,614,000 -7,844,000 -1,875,000 
          investing activities:
                                  
          purchases of property and equipment
        -1,597,000 -1,777,000 -687,000 -1,578,000 -1,893,000 -2,716,000 -3,889,000 -2,878,000 -2,910,000 -3,450,000 -15,236,000 -25,356,000 -4,559,000 -39,734,000 -36,572,000 -27,219,000 -28,136,000 -27,618,000 -20,227,000 -14,568,000 -38,865,000 -21,339,000 -509,000 -6,739,000 -8,079,000 -6,556,000 
          purchases of marketable securities
        -24,714,000  -49,498,000                        
          proceeds from maturities of marketable securities
        25,000,000 25,200,000 50,000,000   12,808,000 12,974,000 12,494,000 19,146,000 19,289,000 31,896,000 1,346,000 8,058,000            
          net cash from investing activities
        -1,311,000 -1,805,000 -8,801,000 -939,000 -1,893,000 -51,592,000 -3,618,000 11,947,000 10,632,000 13,098,000 4,900,000 -4,462,000 119,956,000 -33,172,000 -32,630,000 -27,527,000 -257,558,000 -27,618,000 -20,227,000 -14,568,000 -44,316,000 -22,266,000 -1,310,000 -6,739,000 -8,079,000 -6,581,000 
          financing activities:
                                  
          issuance of common stock from exercise of stock options
        273,000        1,638,000    2,400,000    7,826,000          
          payment of contingent consideration
        -8,690,000                          
          net cash from financing activities
        -8,417,000 2,242,000 617,000 3,522,000 422,000 4,517,000 156,000 4,603,000 1,638,000 5,613,000 4,374,000 7,096,000 -3,414,000 5,001,000 2,039,000 6,360,000 2,417,000 8,903,000 6,683,000 16,193,000 3,518,000 7,706,000 486,968,000 8,051,000 -33,819,000 -1,107,000 
          effect of exchange rates changes on cash and cash equivalents
        -73,000                          
          net increase in cash and cash equivalents
        16,319,000   20,651,000 32,994,000  18,335,000 24,043,000 -3,503,000                  
          cash and cash equivalents at beginning of period
        473,966,000        359,284,000                  
          cash and cash equivalents at end of period
        490,285,000        355,781,000                  
          supplemental disclosures of cash flow information:
                                  
          net cash paid for (received from) income taxes
        -278,000                          
          noncash investing and financing activities:
                                  
          purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities
        118,000  -166,000 -97,000 398,000  -498,000 -447,000 1,899,000  -6,417,000 -21,351,000 30,668,000  2,611,000 11,656,000 15,023,000       -357,000 2,811,000 -2,019,000 
          issuance of class a common stock for settlement of contingent consideration
        8,703,000                          
          rou assets impairment due to restructuring
                                  
          amortization of right-of-use assets
         2,035,000 1,954,000 1,836,000 1,792,000 1,814,000 1,786,000 1,929,000 2,300,000 1,989,000 2,048,000 1,936,000 2,134,000 1,951,000 1,959,000 1,944,000 1,784,000 1,543,000 1,579,000 2,298,000 1,716,000 1,498,000 1,285,000 1,155,000 1,071,000  
          realized loss on marketable securities
             2,000   3,000 1,715,000              
          proceeds from sales of marketable securities
             271,000 3,017,000 568,000 4,054,000 1,190,000 1,605,000 93,342,000 7,716,000 8,708,000            
          purchase of marketable securities
                     -11,324,000 -29,218,000 -242,329,000          
          asset acquisition
         -652,000                         
          purchase of intangible assets
                   -723,000              
          issuance of common stock from exercise of stock options and employee stock purchase plan purchases
         2,242,000 617,000 3,522,000 422,000 4,517,000 156,000   5,613,000 4,374,000   5,001,000 2,039,000   8,903,000 6,683,000 16,193,000 8,546,000 8,488,000 3,921,000    
          payments on technology license financing arrangement
                                  
          effect of exchange rate changes on cash and cash equivalents
                                  
          cash, cash equivalents and restricted cash at beginning of year
                                  
          cash and cash equivalents at end of year
                                  
          cash paid for interest
                 436,000 841,000 1,222,000 1,670,000 528,000 
          cash paid for taxes
         456,000 617,000 856,000 462,000 778,000 2,823,000 1,079,000 961,000 476,000 599,000 1,305,000 2,547,000 276,000 330,000 419,000 2,900,000 342,000 480,000 1,016,000 6,822,000 56,000 64,000 43,000 117,000 
          noncash investing and financing activities
                                  
          purchases of property and equipment included in accounts payable, accrued expenses and other current liabilities
                                  
          right-of-use assets obtained in exchange for new operating lease liabilities
         35,000 3,055,000       -652,000 277,000 6,893,000  16,562,000       -76,000 7,634,000  
          common stock issued for acquisition of assets
                                 
          purchases of intangible assets
                                 
          effect of exchange rates changes on cash, cash equivalents, and restricted cash
                                  
          net increase in cash, cash equivalents, and restricted cash
                 44,546,000 -16,115,000 -8,941,000 112,441,000     -12,992,000    -145,054,000   -44,590,000 -996,000 
          cash, cash equivalents, and restricted cash at beginning of period
            344,067,000     227,353,000  596,073,000  688,644,000  476,493,000  
          cash, cash equivalents, and restricted cash at end of period
            377,061,000  18,335,000    -16,115,000 -8,941,000 339,794,000  -40,240,000 -38,322,000 320,112,000  -39,643,000 4,751,000 643,957,000  430,008,000 -28,213,000 431,903,000  
          net income
                             -415,573,000     
          adjustments to reconcile net income to net cash from operating activities:
                                  
          lease and asset impairment charges
           114,000 600,000 2,454,000                  
          effect of exchange rates changes on cash, cash equivalents
           360,000 114,000                      
          cash, cash equivalents at beginning of period
                                  
          cash, cash equivalents at end of period
                                  
          acquisition of business, net of cash acquired
                     -2,500,000    -5,451,000      
          effect of exchange rate changes on cash, cash equivalents, and restricted cash
             -269,000 156,000 -3,000 -48,000 77,000 -85,000 -49,000 24,000 251,000             
          cash, cash equivalents, and restricted cash at beginning of year
                                  
          cash, cash equivalents, and restricted cash at end of year
                                  
          payments on financing arrangement
                  -5,814,000  -5,409,000  -5,028,000 -2,000 -5,846,000  
          asset impairment charges
                                  
          accrued contingent liabilities
                         -29,497,000 -15,352,000 676,000 -33,385,000 2,382,000 1,862,000 4,656,000 6,157,000 
          contingent consideration payable related to business acquisition
                                  
          lease impairment charges
                                 
          contingent consideration payable from business acquisition
                      1,500,000          
          loss on disposal of property and equipment
                     631,000 450,000   13,000 36,000 30,000     
          loss on extinguishment of debt
                             1,521,000  
          amortization of premium and accretion of discount on marketable securities
                     206,000 210,000 272,000 183,000          
          class a common stock issued for in-process research and development
                                  
          accretion of discount on term loan
                             17,000 29,000 
          acquisition of intangible assets
                             -927,000     
          payments on term loans
                             -31,256,000  
          proceeds from issuance of common stock upon initial and follow-on public offerings, net of issuance costs
                                  
          net decrease in cash, cash equivalents, and restricted cash
                      -40,240,000 -38,322,000 -275,961,000   4,751,000 -44,687,000      
          effect of exchange rates on changes in cash, cash equivalents, and restricted cash
                       -192,000 -18,000 -82,000 117,000 6,000 193,000 -319,000 -21,000 -7,000 -116,000 -8,000 
          proceeds from sales and maturities of marketable securities
                        12,907,000          
          deferred rent, noncurrent
                                 -111,000 
          proceeds from borrowings under revolver
                                 
          payments on borrowings under revolver
                                 
          other assets
                          131,000 52,000 165,000 -112,000 392,000 -1,756,000 -1,210,000 -300,000 
          proceeds from issuance of common stock from follow-on public offering, net of issuance costs
                                  
          stock-based compensation
                                6,718,000 5,075,000 
          proceeds from term loans
                                  
          payments on capital lease obligations
                                  
          proceeds from issuance of preferred stock, net of issuance costs
                                  
          proceeds from issuance of common stock upon initial and follow-on public offering, net of issuance costs
                                  
          deferred offering costs
                                  
          deferred offering costs in accounts payable and accrued expenses and other current liabilities
                                  
          debt discount in accrued expenses and other current liabilities
                                  
          proceeds from issuance of common stock upon exercise of stock options
                                3,283,000 748,000 
          proceeds from issuance of common stock upon initial public offering, net of issuance costs
                                 -1,855,000 
          repurchase of unvested common stock related to early exercised shares
                                  
          conversion of convertible preferred stock into common stock upon initial public offering
                                 
          purchase of technology licenses under financing arrangement